Select Page

Efficacy with Eleview®

Efficacy with Eleview®

Eleview® is a long-lasting, easy-to-inject submucosal injection agent for polypectomy, endoscopic mucosal resection (EMR), and endoscopic submucosal dissection (ESD) procedures.1,2

Watch an EMR of the transverse colon

Dr. Douglas Rex performs an EMR of the transverse colon with Eleview®. View transcript

Long-lasting lift

Unlike normal saline-injected cushions that may collapse in minutes, Eleview® creates immediate cushions that last for up to 45 minutes.2 This longer duration allows the endoscopist to work efficiently and effectively for easy and safe resection procedures.1,2

  • Creates an immediate and long-lasting cushion that holds for up to 45 minutes2
  • Designed to require fewer reinjections2
  • Maintains cushions without releasing liquid after resection2

Eleview® creates immediate cushions that last2

Eleview® lift for up to 45-minute cushion duration chart

Increases margin visibility

Upon injection, Eleview® reconfigures to form a colored cushion that pushes the mucosa away from the submucosa.1 This offers increased visibility of target lesion margins that may add to procedural efficiency.1

Submucosa elevated by Eleview®
Submucosa elevated by Eleview®
Submucosa elevated by Eleview®
Methylene blue is included in Eleview®

Plus icon expand image
Minus icon collapse image
Methylene blue contrast and staining agent:

  • Provides detailed delineation of lesion edges1-3
  • Stains the submucosal tissue1-3
  • Facilitates identification of muscle injury and enhances the post-resection view1-3
Plus icon expand image
Minus icon collapse image
Muscularis mucosa
Plus icon expand image
Minus icon collapse image
Submucosa elevated by Eleview®

Reliable cushions

Eleview® is a submucosal injection agent that lifts and lasts longer than normal saline,2 empowering the endoscopist to perform safe and efficient resections.1

Eleview® injection and cushion formation sequence

1. Injection: Inject to form a submucosal cushion of optimal height and duration.1
Eleview® submucosal injection
2. Cushion formation: Reconfigures to form a colored cushion that pushes the mucosa away from the submucosa.1 Methylene blue provides detailed delineation of the lesion edges.1-3
Eleview® cushion formation
3. Resection: Cushions last for up to 45 minutes, facilitating an easy and safe resection procedure.1,2
Eleview® submucosal injection
4. Post-resection: Methylene blue stains the submucosa, enhances the post-resection view, and facilitates identification of muscle injury.3
Eleview® post-resection site

Designed to lower the risk of perforation

Eleview® is designed to lower the risk of perforation by helping to visualize the margins of the target lesions.1 Improved margin visualization helps decrease risk of damage to the external muscular layer, which could lead to perforation.1

View an EMR of the cecum

A 1-cm serrated lesion in the cecum with margin
delineation after injection with Eleview®. View transcript

Range of polyps

Eleview® may be used on a range of polyps including rectal lesions, those located in the cecum, across folds, on stomach lesions, and in the esophagus.

For a range of polyps regardless of their size, location, or type

Large

Eleview® is appropriate for a range of polyp types

Larger

flat polyp

Eleview® is appropriate for a range of polyp types

Flat

Eleview® is appropriate for a range of polyp types

Laterally spreading

On cross folds

Eleview® is appropriate for a range of polyp types

On cross folds

On right side or cecum

Eleview® is appropriate for a range of polyp types

On right side or cecum

back-to-top

INDICATIONS FOR USE

Eleview® submucosal injectable composition is intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers, or other gastrointestinal mucosal lesions, prior to excision with a snare or endoscopic device.

CONTRAINDICATIONS

Patients with known sensitivity to any of the components contained in Eleview®.

WARNINGS AND PRECAUTIONS

  • The endoscopist injecting Eleview® must be experienced in the administration technique.
  • The safety of Eleview® has not been established in pregnant or lactating women, or in children under 18 years of age.
  • Eleview® is provided in single-use ampoules. Eleview® should not be reused after the first opening. Any emulsion not injected during the procedure should not be reused for another endoscopic procedure.
  • Do not use if the primary packaging (ampoule) or secondary packaging (aluminum pouch) is damaged.
  • Do not use if the twist-off cap is damaged.
  • Do not use if the emulsion is not clear, shows any signs of opalescence, or contains floating or precipitated visible particles.
  • The product compatibility with other substances has not been tested.

ADVERSE REACTIONS

Rarely, local bleeding and/or inflammatory reaction could occur which may or may not be associated with Eleview®.

DOSAGE AND ADMINISTRATION

The administered dose of Eleview® should be determined based on the dimensions of the lesion to be removed. Inject into the submucosa the amount of Eleview® needed to form a submucosal cushion of optimal height and shape for the lesion to be removed. During the procedure do not exceed a total dose of 50 mL per patient, either in single or in multiple administrations.

Please see Instructions for Use for complete Important Safety Information.